Photosensitizer-Conjugated Human Serum Albumin Nanoparticles for Effective Photodynamic Therapy

Authors
Jeong, HayoungHuh, MyungSookLee, So JinKoo, HeebeomKwon, Ick ChanJeong, Seo YoungKim, Kwangmeyung
Issue Date
2011-03
Publisher
IVYSPRING INT PUBL
Citation
THERANOSTICS, v.1, pp.230 - 239
Abstract
Photodynamic therapy (PDT) is an emerging theranostic modality for various cancers and diseases. The focus of this study was the development of tumor-targeting albumin nanoparticles containing photosensitizers for efficient PDT. To produce tumor-targeting albumin nanoparticles, the hydrophobic photosensitizer, chlorin e6 (Ce6), was chemically conjugated to human serum albumin (HSA). The conjugates formed self-assembled nanoparticle structures with an average diameter of 88 nm under aqueous conditions. As expected, the Ce6-conjugated HSA nanoparticles (Ce6-HSA-NPs) were nontoxic in their native state, but upon illumination with the appropriate wavelength of light, they produced singlet oxygen and damaged target tumor cells in a cell culture system. Importantly, when the nanoparticles were injected through the tail vein into tumor-bearing HT-29 mice, Ce6-HSA-NPs compared with free Ce6 revealed enhanced tumor-specific biodistribution and successful therapeutic results following laser irradiation. These results suggest that highly tumor-specific albumin nanoparticles have the potential to serve not only as efficient therapeutic agents, but also as photodynamic imaging (PDI) reagents in cancer treatment.
Keywords
CARRIERS; DELIVERY; CANCER; Photodynamic therapy; Human Serum Albumin Nanoparticles
ISSN
1838-7640
URI
https://pubs.kist.re.kr/handle/201004/130568
DOI
10.7150/thno/v01p0230
Appears in Collections:
KIST Article > 2011
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE